Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

BACKGROUND<br/> The replication-competent recombinant vesicular stomatitis virus (rVSV)–based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety and immunogenicity testing before its use in West Africa. <br/><br/>METHODS<br/> We performed...

詳細記述

書誌詳細
主要な著者: Agnandji, S, Huttner, A, Zinser, M, Bejon, P
フォーマット: Journal article
出版事項: Massachusetts Medical Society 2016